Inflammation Linked to Cancer-Related Fatigue: New Research Insights
New Research Links Inflammation to Cancer-Related Fatigue
October 10, 2023 — A groundbreaking study from researchers at the University of California, Los Angeles (UCLA) has unveiled significant insights into the complex relationship between inflammation and cancer-related fatigue, a debilitating condition affecting many cancer patients. The findings, published in the peer-reviewed journal CANCER, highlight how inflammatory responses may contribute to various dimensions of fatigue experienced by individuals battling cancer.
Cancer-related fatigue is more than just tiredness; it encompasses physical, emotional, and cognitive exhaustion that can linger long after treatment. While previous studies suggested that inflammation triggered by tumors or cancer therapies might be a key factor in this fatigue, comprehensive investigations into inflammatory activity throughout the cancer continuum have been limited.
In this study, researchers examined 192 women diagnosed with early-stage breast cancer, assessing them before they underwent radiation or chemotherapy and continuing for 18 months post-treatment. Participants reported their fatigue levels across different dimensions—general, physical, mental, and emotional—while providing blood samples to measure protein markers of inflammation, including pro-inflammatory cytokines TNF-α and IL-6, as well as downstream markers sTNF-RII and CRP.
The results were striking. Higher levels of TNF-α, sTNF-RII, and IL-6 were consistently linked to increased general fatigue, characterized by overwhelming tiredness. This correlation persisted even after adjusting for factors such as age, race, education, body mass index, and cancer stage. Additionally, physical fatigue, marked by feelings of weakness and heaviness, was similarly associated with elevated levels of these inflammatory markers. Interestingly, the study found that higher levels of TNF-α and sTNF-RII correlated with lower emotional fatigue, while no significant links were identified between mental fatigue and inflammatory markers.
“Our findings indicate that inflammation plays a role in some aspects of cancer-related fatigue, but not others, and that these effects persist well after treatment,” said lead author Dr. Julienne E. Bower. “This is critical for developing targeted treatments for this common and disabling symptom.”
As researchers continue to explore the intricate connections between inflammation and fatigue, these findings pave the way for potential new therapeutic strategies aimed at alleviating one of the most challenging aspects of cancer recovery.
For further details, the full study can be accessed in CANCER at this link.
